![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210105005158/en/Phoenix-PharmaLabs-Strengthens-its-Position-as-a-Developer-of-Next-Generation-Pain-Pharmaceuticals-with-the-Acquisition-of-a-Portfolio-of-NOPMu-Agonist-Compounds
https://www.businesswire.com/news/home/20201221005188/en/Phoenix-PharmaLabs-Announces-New-Investment-Offering-with-Netcapital
http://www.globenewswire.com/news-release/2020/05/13/2032992/0/en/BridgeBio-Pharma-s-Phoenix-Tissue-Repair-Provides-Updates-to-its-Recessive-Dystrophic-Epidermolysis-Bullosa-RDEB-Program-and-Announces-New-Leadership-Appointments.html